Transforming radiology
worldwide with innovative AI

Trusted by radiologists worldwide, Oxipit delivers clinically validated and certified radiology AI solutions that address the global radiologist shortage and improve diagnostic quality.

What started with chest X-ray AI has now expanded into three comprehensive suites covering chest X-ray, chest CT, and musculoskeletal imaging. Our flagship innovation, ChestLink—the world’s first and only autonomous AI for healthy chest X-ray reporting—safely identifies normal studies with 99.9% precision, automating up to 40% of cases and removing them from the worklist.

Each suite is designed to streamline radiology workflows, reduce oversights, and support confident decision-making, allowing you to focus on what matters most: exceptional patient care.

Discover our innovative AI portfolio

CXR Suite

CT Suite

MSK Suite

Stay up-to-date
with the latest from Oxipit

Explore our most recent blog posts, news, webinars, and research studies, designed to
keep you informed about advancements in radiology AI and industry insights.

Oxipit expands radiology AI portfolio beyond CXR with CT Eye™ and MSK Eye™

2026 February 10th

Oxipit announces the launch of CT Eye™ and MSK Eye™, two new CE-certified AI solutions expanding its radiology AI portfolio beyond chest X-ray into chest CT and musculoskeletal X-ray workflows. Oxipit will demonstrate these solutions at the European Congress of Radiology (ECR) 2026 this March, alongside its globally adopted CXR Suite, known for introducing the world’s only autonomous healthy chest X-ray reporting solution.

Diagnostikum Group selects Oxipit CXR Suite after rigorous multi-vendor evaluation

2025 November 18th

Vilnius, Lithuania – November 18, 2025 – Oxipit, a leading provider of AI-driven medical imaging solutions, announced that Diagnostikum Group, one of Austria’s foremost diagnostic providers, has chosen the Oxipit CXR Suite to enhance chest X-ray workflows across its network. The implementation will take place through Oxipit’s partner DeepC, ensuring seamless integration into Diagnostikum’s existing clinical environment.

Oxipit welcomes new strategic advisor

2025 August 19th

August 19, 2025—Vilnius, Lithuania—Oxipit, a leading AI-driven healthcare technology company, is pleased to announce that Kevin Shah has joined the company as Strategic Advisor, bringing invaluable guidance as the company builds on recent sales momentum and prepares for the launch of its upcoming MSK and CT solutions. His deep market knowledge and proven commercial experience align closely with Oxipit’s mission to lead the future of autonomous radiology—delivering trusted AI solutions that empower equitable, precise healthcare, transform diagnosis, and improve patient care worldwide.

Case study: embracing AI for efficient chest x-ray reporting and quality assurance

At Šeškinės Poliklinika, one of Lithuania’s largest public clinics, radiologists process over 2,700 chest X-rays each month. To meet rising demand without compromising care, the clinic implemented the Oxipit CXR Suite—a portfolio of AI tools built for chest X-ray workflows. Today, Oxipit’s AI autonomously reports up to 80% of routine, healthy chest X-rays, allowing radiologists to focus on more complex cases. Integrated real-time quality assurance adds a second layer of diagnostic safety, supporting confident, consistent decisions. This case study explores how the clinic moved from early adoption to measurable results—with faster reporting, reduced workload, and AI now fully embedded in everyday practice.

Oxipit partners with Vestre Viken to pilot AI in chest X-ray diagnostics

Bærum, Norway – June 5, 2025 – Oxipit, a leading provider of AI-driven medical imaging solutions, announced the collaboration with Vestre Viken Health Trust in launching Norway's first pilot project for AI-powered thoracic (lung) X-ray imaging. This initiative will evaluate ChestLink, the world’s first autonomous AI tool for reporting normal chest X-rays.

Diagnostic confidence at speed: how FIDI uses Oxipit AI through CARPL in emergency care

FIDI (Fundação Instituto de Pesquisa e Estudo de Diagnóstico por Imagem) is one of Latin America's largest radiology service providers, delivering more than 400,000 diagnostic studies each month across 90 sites in Brazil. In 2024, FIDI introduced Oxipit’s AI-powered chest X-ray support tool in emergency departments, where fast, consistent interpretation is critical and real-time radiologist input is not always available.

All News